If you need more lookups,
subscriptions start at $34 USD/month.
Matthew Gantz Location
Philadelphia, PA, US
Matthew Gantz Work
2021 -now CEO @
2012 -2023 Member Board of Directors @
2017 -2021 Chief Executive Officer @
2015 -2020 Member Board of Directors @ Lifescience Pennsylvania
2009 -2016 Executive Vice President, US @
2006 -2008 CEO @ Acureon Pharmaceuticals
2003 -2005 CEO @ Hydrabiosciences
2000 -2003 Division VP, Europe and ROW @ Chiron Corporation (now Novartis)
1996 -2000 GM, Europe @ PathoGenesis
1993 -1996 Product Manager @
Matthew Gantz Education
Harvard Business School
Master of Business Administration - MBA (Business Administration and Management, General)
1991-1993
Princeton University
BA (History)
1983-1987
Matthew Gantz Skills
Leadership
Strategic Planning
Strategy
Cross-functional Team Leadership
Marketing
Product Launch
Entrepreneurship
Lifesciences
Biotechnology
Commercialization
Start-ups
Pharmaceutical Industry
Marketing Strategy
Clinical Development
Drug Development
Oncology
Biopharmaceuticals
Mergers & Acquisitions
Technology Transfer
Product Management
Business Strategy
Clinical Trials
Venture Capital
Regulatory Affairs
Life Sciences
Corporate Development
Product Development
Public Speaking
Cross Functional Team
Start Ups
Cross Functional Team Leadership
Change Management
Project Management
Mergers and Acquisitions
Matthew Gantz Summary
Matthew Gantz, based in Philadelphia, PA, US, is currently a CEO at Castle Creek Biosciences, Inc.. Matthew Gantz brings experience from previous roles at Swedish Orphan Biovitrum, OxThera, Lifescience Pennsylvania and BTG. Matthew Gantz holds a 1991 - 1993 Master of Business Administration - MBA in Business Administration and Management, General @ Harvard Business School. With a robust skill set that includes Leadership, Strategic Planning, Strategy, Cross-functional Team Leadership, Marketing and more. Matthew Gantz has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Matthew Gantz?
Find contact details for 700 million professionals.